
CBISChem4D02119516192D

 34 38  0  0  1  0  0  0  0  0999 V2000
   -3.5512    0.9222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5512   -0.5827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2480   -1.3351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9449   -0.5827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9449    0.9222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2480    1.6746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3584   -1.3351    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.6615   -0.5827    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.6615    0.9222    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.3584    1.6746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3094    0.6097    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3343   -2.4846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3940   -2.6384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6009   -1.7428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9603   -1.3320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4035    1.6348    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
    5.8394    1.2002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0630    3.0956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1813   -0.2651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6210   -0.7008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7196    0.3275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3768    1.7936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9367    2.2294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1544   -0.1074    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.1570    4.1209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5948    3.6945    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -4.8503   -1.3331    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1497   -0.5832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4489   -1.3331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7504   -0.5868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.0474   -1.3408    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.0431   -2.8411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7415   -3.5874    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4446   -2.8334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0  0  0  0
  3  2  1  0  0  0  0
  4  3  2  0  0  0  0
  5  4  1  0  0  0  0
  6  5  2  0  0  0  0
  6  1  1  0  0  0  0
  7  4  1  0  0  0  0
  8  7  1  0  0  0  0
  9  8  1  0  0  0  0
  9 10  1  0  0  0  0
 10  5  1  0  0  0  0
  9 11  1  1  0  0  0
  7 12  1  1  0  0  0
  7 13  1  6  0  0  0
 14 12  1  0  0  0  0
 14 11  1  0  0  0  0
  8 15  1  1  0  0  0
 16 11  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  1  6  0  0  0
 19 17  2  0  0  0  0
 20 19  1  0  0  0  0
 21 20  2  0  0  0  0
 22 21  1  0  0  0  0
 23 22  2  0  0  0  0
 23 17  1  0  0  0  0
 24 21  1  0  0  0  0
 25 18  1  0  0  0  0
 26 23  1  0  0  0  0
 27  2  1  0  0  0  0
 27 28  1  0  0  0  0
 28 29  1  0  0  0  0
 29 30  1  0  0  0  0
 30 31  2  0  0  0  0
 32 33  2  0  0  0  0
 33 34  1  0  0  0  0
 34 29  2  0  0  0  0
 31 32  1  0  0  0  0
M  END
>  <SubstanceID>
OPS-0017843

>  <Name>
{10-[(1R)-1-(2-chloro-4-fluorophenyl)propyl](13S,1R,9R)-1,13-dimethyl-10-azatricyclo[7.3.1.0<2,7>]trideca-2,4,6-trien-4-yl}(pyrimidin-5-ylmethyl)amine

>  <Synonyms.Name>


>  <ProjectID>
CNS Project

>  <Formula>
C28H32ClFN4

>  <MolWt>
479.04

>  <Libraries.Source>


>  <Libraries.VendorCompoundID>


>  <Background Info.Description>


>  <Background Info.FileName>


>  <ClogP>
5.777

>  <ALogP>


>  <LogD>


>  <PolarSurfaceArea>


>  <tPSA>
39.99

>  <HBondAcceptor>


>  <HBondDonor>


>  <RotatableBond>


>  <Stereochemistry>


>  <Scientist>
fulong wu

>  <Documents.DocumentID>
DN-000146
DN-000149
DN-000152
DN-000158

>  <Documents.Title>
LXR compounds efficacy study in B16F10 subQ model(5th)
EA of 17843.0003
COA of 17843.0003
LXR compounds efficacy study in B16F10 subQ model(6th)

>  <Documents.KeyWords>
In vivo efficacy study:
OPS-13825 80mpk (IP&PO), OPS-17601 80mpk(IP&PO), 120mpk IP, OPS-17843 80mpk(IP&PO), 120mpk IP, OPS-17842 80mpk PO, OPS-17850 80mpk PO and OPS-2071 10mpk PO were evaluated in B16F10(5th) subQ model.

EA of 17843.0003
COA of 17843.0003
In vivo efficacy study:
OPS-17601, 17842, 17843 and 17850 80 mpk PO and RGX-104 80mpk PO/IP were evaluated in B16F10 subQ model.

>  <KeyWords>


>  <XtalData>


>  <UserID>
fulong wu

>  <RegistrationDate>
07/13/2021

>  <Comments>
Chiral pure

>  <ID>
17850

$$$$
